Anastasis Biotec
London
About Anastasis Biotec
Anastasis Biotec is a developer of a novel and proprietary treatment made for patients with cancers that express specific ‘cancer-driving mutations’.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $298.7K
- Last round: Equity Crowdfunding (Jul 2020)
- Website: anastasisbiotec.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/anastasis-biotec-148619 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.